DSP was conducted on the previously described glioma and BrM TMAs using the GeoMx Immuno-Oncology Proteome Atlas (IPA), the Whole Transcriptomic Assay (WTA) (Bruker Spatial Biology) and custom pan-bacterial 16S probes (Fig. 4a). The gene discussed is DSP; the disease is central nervous system cancer.